Transphorm Q3 EPS $(0.11) Misses $(0.09) Estimate, Sales $4.67M Miss $6.17M Estimate
Portfolio Pulse from Happy Mohamed
Transphorm (NASDAQ:TGAN) reported Q3 earnings with losses of $(0.11) per share, missing the $(0.09) estimate, and sales of $4.67M, below the $6.17M estimate. Despite these misses, there's a year-over-year improvement in both earnings and sales.
February 20, 2024 | 9:29 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Transphorm reported Q3 losses greater than expected and sales below estimates, but showed year-over-year improvement.
Missing both EPS and sales estimates typically has a negative short-term impact on a company's stock price. However, the year-over-year improvement in both metrics might mitigate some of the negative sentiment.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100